Cost-Analysis of the Different Treatment Modalities in X-Linked Dystonia-Parkinsonism.

ABSTRACT: Background: X-linked dystonia-parkinsonism (XDP) is a debilitating disease endemic in the Philippines. Several oral medications as well as botulinum toxin A (BoNT-A) injection and deep brain stimulation (DBS) surgery appear to be the cornerstone of treatment in XDP, which are commonly used in combination. Being a chronic progressive disease, it is an economic burden to the patient and their families. Thus, we aim to perform a comparative analysis of the associated healthcare costs for the therapeutic options used in XDP. Methodology: A questionnaire assessing the healthcare costs in the management of XDP was designed and administered through an interview with the XDP patients or their caregivers. We analyzed the data and a bootstrap analysis was also done to obtain a more gen

SUBMITTER: De Roxas RC 

PROVIDER: S-EPMC6521807 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature